🆚 Epic vs. NextGen
- 📈 Epic is much more popular than NextGen.
- 🌍 Epic is more popular in all countries.
Statistics based on 3.3M+ analyzed websites. About this data
Type
Electronic health record system
Electronic health record system
About
Epic is a cloud-based EHR solution that includes MyChart, a secure patient portal and online scheduling service.
NextGen is a cloud-based EHR system that includes practice management, patient self-scheduling, virtual visits, billing, advanced analytics, and more.
Headquarters
Verona, Wisconsin, United States
Irvine, California, United States
Categories
Popularity
Determined by the number of sites using each technology.
The Epic EHR software is 8 times more popular than NextGen.
Total websites
Market share
EHR
Scheduling
Popularity by country
Determined by the number of sites detected from each country.
Epic is more popular than NextGen in all countries.
United States
Canada
United Kingdom
Saudi Arabia
Awards
- 🥈 Second most popular in the United States in the EHR category.
- 🔥 13rd most popular in the United States in the Scheduling category.
- ⭐ 9th most popular in the United States in the EHR category.
- ⬆️ 37th most popular in the United States in the Scheduling category.
Popularity by domain category
Determined by the number of sites in each category.
Epic is more popular than NextGen in all market segments.
Health
Marketing/Merchandising
Business
Education/Reference
Non-Profit/Advocacy/NGO
Public Information
Real Estate
General News
Finance/Banking
Potentially Unwanted Programs
Top sites
Top-ranked sites that use these technologies.
Compare alternatives
Technologies with similar characteristics.
Oracle Health🗃️ About This Data
- We evaluate the popularity of technologies based on the number of websites where we detect their usage.
- Technologies without a detectable web footprint, and those we do not track, are not reflected in the calculated market share.
- This report is based on the analysis of 3,375,483 websites.
- Statistics were last calculated on .
- For more details, see our methodology and disclaimer.